CNS Efficacy of Osimertinib Plus Savolitinib in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With MET Overexpression and/or Amplification: A Brief Report
CNS Efficacy of Osimertinib Plus Savolitinib in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With MET Overexpression and/or Amplification: A Brief Report. // JTO Clinical and Research Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2666364326001402?dgcid=rss_sd_all
CNS Efficacy of Osimertinib Plus Savolitinib in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With MET Overexpression and/or Amplification: A Brief Report. JTO Clinical and Research Reports. https://www.sciencedirect.com/science/article/pii/S2666364326001402?dgcid=rss_sd_all
“CNS Efficacy of Osimertinib Plus Savolitinib in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With MET Overexpression and/or Amplification: A Brief Report.” JTO Clinical and Research Reports.
@article{article99068,
title = {CNS Efficacy of Osimertinib Plus Savolitinib in Epidermal Growth Factor Receptor-Mutated Advanced Non-Small Cell Lung Cancer With MET Overexpression and/or Amplification: A Brief Report},
journal = {JTO Clinical and Research Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2666364326001402?dgcid=rss_sd_all}
}